Pharmacogenomics

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This is a new field and combines pharmacology and genomics to develop effective and safe medications and doses that will be designed according to a person’s genetic organization. The field of pharmacogenomics is still in its early stage. Its use is currently quite limited, but new approaches are under study in clinical trials. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics.

 

  • Genome
  • Drug response
  • Epigenetics
  • Genotyping
  • Genome sequencing
  • Polypharmacy
  • Drug labeling

Related Conference of Pharmacogenomics

February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
June 08-09, 2026

20th World Drug Delivery Summit

London, UK
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in